C. Lawrence

521 total citations
11 papers, 237 citations indexed

About

C. Lawrence is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, C. Lawrence has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Molecular Medicine. Recurrent topics in C. Lawrence's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Antibiotic Use and Resistance (3 papers). C. Lawrence is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Antibiotic Use and Resistance (3 papers). C. Lawrence collaborates with scholars based in France, United States and Spain. C. Lawrence's co-authors include Charles S. Fuchs, J. A. Meyerhardt, Craig C. Earle, Matthew H. Kulke, Pankaj Bhargava, Keith Stuart, Jeffrey W. Clark, Peter C. Enzinger, M. Attawia and J. Salomon and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

C. Lawrence

11 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Lawrence France	7	105	92	79	61	55	11	237
Ambrogio Curtolo Italy	8	76 0.7×	14 0.2×	76 1.0×	61 1.0×	24 0.4×	14	240
Antonella Frattari Italy	8	114 1.1×	21 0.2×	64 0.8×	29 0.5×	15 0.3×	18	210
И. О. Стома Belarus	7	81 0.8×	85 0.9×	34 0.4×	68 1.1×	3 0.1×	41	229
Rosaria Lionello Italy	8	55 0.5×	11 0.1×	62 0.8×	36 0.6×	11 0.2×	11	150
Jon Hiles United States	7	85 0.8×	37 0.4×	109 1.4×	32 0.5×	2 0.0×	8	246
Ahmad Ibrahim Lebanon	8	84 0.8×	69 0.8×	48 0.6×	25 0.4×	2 0.0×	27	222
Semaria Solomon Ethiopia	7	73 0.7×	8 0.1×	15 0.2×	29 0.5×	31 0.6×	13	172
Andrea Zimmer United States	7	81 0.8×	142 1.5×	24 0.3×	68 1.1×	2 0.0×	15	265
Esma Eren Türkiye	7	45 0.4×	15 0.2×	22 0.3×	50 0.8×	9 0.2×	39	120
Karianne Wiger Gammelsrud Norway	7	43 0.4×	18 0.2×	33 0.4×	54 0.9×	2 0.0×	15	135

Countries citing papers authored by C. Lawrence

Since Specialization

Citations

This map shows the geographic impact of C. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lawrence more than expected).

Fields of papers citing papers by C. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lawrence. The network helps show where C. Lawrence may publish in the future.

Co-authorship network of co-authors of C. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lawrence. A scholar is included among the top collaborators of C. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lawrence. C. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bandyopadhyay, Subhayu, et al.. (2020). Can We Translate Non-inferiority Clinical Trial into Practice? Real World Outcome of Sunitinib and Pazopanib as First Line Targeted Therapy in Metastatic Renal Cell Carcinoma: UK Centre Experience. Clinical Oncology. 32(5). e131–e131. 1 indexed citations

Farfour, Éric, Anis Larbi, Jeanne Couturier, et al.. (2019). Asymptomatic carriage of extensively drug-resistant bacteria (eXDR), a simple way to assess spontaneous clearance. Journal of Hospital Infection. 104(4). 503–507. 2 indexed citations

Davido, Benjamin, Rui Batista, Hafedh Fessi, et al.. (2018). Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak. Médecine et Maladies Infectieuses. 49(3). 214–218. 26 indexed citations

Bilavsky, Efraim, Elizabeth Temkin, Yaffa Lerman, et al.. (2014). Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres. Clinical Microbiology and Infection. 20(11). O804–O810. 24 indexed citations

Alvarez, Anne‐Sophie, Caroline Allix‐Béguec, Claire Dupont, et al.. (2013). Patient nostril microbial flora: individual-dependency and diversity precluding prediction of Staphylococcus aureus acquisition. Clinical Microbiology and Infection. 20(1). 70–78. 13 indexed citations

Izdebski, Radosław, Anna Baraniak, J. Fiett, et al.. (2012). Clonal Structure, Extended-Spectrum β-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four Countries. Antimicrobial Agents and Chemotherapy. 57(1). 309–316. 53 indexed citations

Kulke, Matthew H., Keith Stuart, Craig C. Earle, et al.. (2006). A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors. Journal of Clinical Oncology. 24(18_suppl). 4044–4044. 68 indexed citations

Meyerhardt, Jeffrey A., Keith Stuart, Andrew X. Zhu, et al.. (2006). Phase II study of FOLFOX, bevacizumab and erlotinib as initial therapy for patients with metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 24(18_suppl). 3545–3545. 6 indexed citations

Blaszkowsky, Lawrence S., D. P. Ryan, J. W. Clark, et al.. (2005). A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). 4099–4099. 24 indexed citations

10.

Lawrence, C., E Ronco, O Dizien, et al.. (2004). Intérêt du dépistage actif des bactéries multirésistantes dans les services de médecine physique et réadaptation. Pathologie Biologie. 52(10). 602–606. 3 indexed citations

11.

Lawrence, C., et al.. (1996). Consecutive isolation of homologous strains of methicillin-resistant and methicillin-susceptible Staphylococcus aureus from a hospitalized child. Journal of Hospital Infection. 33(1). 49–53. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact